Experiences of National traditional Chinese medicine Master LI Diangui in treating reflux esophagitis based on "the theory of turbid toxin" from "depression, stagnation and reversal"
-
摘要: 反流性食管炎(reflux esophagitis，RE)是一种常见的胃食管反流病，因受情绪、生活方式等因素影响较大，反复难愈，严重影响患者的生活质量。国医大师李佃贵教授基于多年临床经验总结出“浊毒理论”，认为RE的病机主要由肝气郁结，浊毒阻滞，浊气上逆所致，与情志密切相关。本文总结李佃贵教授在浊毒理论指导下，分别从郁、滞、逆3个方面深入阐述RE的病机演变，以解郁、行滞、降逆为治疗要则，在临床取得较好疗效，为RE的治疗提供了有益的诊疗思路。Abstract: Reflux esophagitis (RE), a prevalent form of gastroesophageal reflux disease, is influenced by a multitude of factors including emotional states and lifestyle choices. It is characterized by its recurrent nature and refractoriness to treatment, which significantly impairs the quality of life in affected individuals. Professor LI Diangui, a National Master of traditional Chinese medicine, based on years of clinical experience summarised "the theory of turbid toxin", believes that the mechanism of RE is mainly caused by liver Qi stagnation, turbid toxin obstruction, turbid Qi upward reversal of the cause, and is closely related to emotions and feelings.This article summarises professor LI Diangui's in-depth description of the evolution of RE pathogenesis from depression, stagnation and reversal under the guidance of turbid toxicity theory, and the treatment principles of resolving depression, promoting stagnation and lowering reversal, which provides a useful diagnostic and therapeutic idea for the treatment of RE.
-
-
[1] 汪忠镐, 吴继敏, 胡志伟, 等. 中国胃食管反流病多学科诊疗共识[J]. 中华胃食管反流病电子杂志, 2020, 7(1): 1-28.
[2] Zhang D, Liu S, Li Z, et al. Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: update from the GBD 2019 study[J]. Ann Med, 2022, 54(1): 1372-1384. doi: 10.1080/07853890.2022.2074535
[3] Zamani M, Alizadeh Tabari S, Chan WW, et al. Association Between Anxiety/Depression and Gastroesophageal Reflux: A Systematic Review and Meta-Analysis[J]. Am J Gastroenterol, 2023, 118(12): 2133-2143. doi: 10.14309/ajg.0000000000002411
[4] 郑倩, 张昊, 谭家腾, 等. 胃食管反流病与抑郁、焦虑相关性的临床研究[J]. 中国实验诊断学, 2022, 26(1): 41-44.
[5] 褚源, 胡焕标, 吴凯, 等. 胃食管反流病患者精神心理因素、生活质量、睡眠质量的分析以及联用黛力新治疗的疗效观察[J]. 现代消化及介入诊疗, 2019, 24(10): 1095-1099.
[6] 张迎春, 何海艳, 杨欣, 等. 中药复方结合分级降阶梯应用PPI治疗胃食管反流病诊疗思路及优势浅析[J]. 现代中西医结合杂志, 2021, 30(13): 1474-1478.
[7] 徐伟超, 李佃贵, 刘建平, 等. 浊毒理论创新中医病因病机学[J]. 中国中西医结合杂志, 2019, 39(8): 913-915.
[8] 李佃贵. 从浊毒理论的建立与应用谈中医学创新与发展[J]. 中医杂志, 2020, 61(22): 1938-1940.
[9] 张贤翠, 张阳, 石磊, 等. 李军祥从"浊"论治胃食管反流病经验[J]. 中国中医药信息杂志, 2022, 29(6): 128-131.
[10] 霍磊, 张欢润, 詹向红, 等. "肝主疏泄"内涵演变[J]. 中国中医基础医学杂志, 2021, 7(10): 1533-1535.
[11] 刘伟, 王兰, 霍云翔, 等. 李佃贵基于浊毒理论运用王氏连朴饮临证思路探析[J]. 上海中医药杂志, 2023, 57(9): 1-5.
[12] 张迪, 姜德友. 基于"土郁夺之"探讨慢性萎缩性胃炎辨治思路[J]. 中医学报, 2023, 38(7): 1416-1422.
[13] 汪志伟, 许卫华, 侯文肖, 等. 基于脾升胃降理论论治反流性咽喉炎[J]. 北京中医药, 2022, 41(7): 776-778.
[14] 李琳琳, 朱方石. 半夏厚朴汤治疗反流性食管炎的理论机制探讨[J]. 中国医药导报, 2021, 18(2): 128-131.
[15] 陈斯. 延胡索化学成分和药理作用研究进展[J]. 中医药信息, 2021, 38(7): 78-82.
[16] 左军, 祁天立, 胡晓阳. 茯苓化学成分及现代药理研究进展[J]. 中医药学报, 2023, 51(1): 110-114.
[17] 杨乾方, 王帆, 叶婷, 等. 黄芪多糖提取工艺、化学结构及药理作用的研究进展[J]. 中草药, 2023, 54(12): 4069-4081.
[18] 倪建成, 范永飞, 叶祖云. 太子参化学成分、药理作用和应用的研究进展[J]. 中草药, 2023, 54(6): 1963-1977.
-
计量
- 文章访问数: 390
- 施引文献: 0
下载: